Cellectis - 48 Year Dividend History | CLLS

Historical dividend payout and yield for Cellectis (CLLS) since 1971. The current TTM dividend payout for Cellectis (CLLS) as of April 24, 2019 is $0.00. The current dividend yield for Cellectis as of April 24, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.857B $0.021B
Cellectis SA is a gene-editing company. The company focused on developing immunotherapies based on gene edited engineered CAR-T cells. Cellectis SA is based in Paris, France.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $110.723B 12.48
Gilead Sciences (GILD) United States $80.369B 10.23
Bio-Techne Corp (TECH) United States $7.248B 48.83